Information for building cells is stored in our genetic material, otherwise known as DNA. It is here that you find all the blueprints for the more than 20,000 different proteins in the human body. Each and every cell requires several thousand different proteins in order to function.
Freiburg researchers map out the atlas of gene regulators in human cardiac cells for the first time. They found more than 100,000 gene switches and mechanisms that are misguided in heart diseases. The atlas could be used to treat heart disease.
If you were to roll every single protein blueprint into one, the information they contain would fit on less than two percent of all DNA. What are the remaining 98 percent of the genomes needed for? The switches that control gene activity are located here. For the first time, a research team led by Dr. Ralf Gilsbach and Prof. Lutz Hein from the Institute of Experimental and Clinical Pharmacology and Toxicology at the University of Freiburg have mapped out the gene regulators in the DNA of human cardiac muscle cells. The findings have been published in the journal Nature Communications.
In order to locate all gene switches, the Freiburg research team used modern sequencing methods to examine the entire genome - DNA, epigenetic markers and RNA - during the development, maturation and disease of human cardiac muscle cells. By analyzing more than a trillion sequencing letters, the team found over 100,000 gene switches. The multitude of data now yields a complete atlas of gene regulators in the life of a cardiac muscle cell. During development and growth, DNA methylation and histone markers control which genes are turned on or off. The atlas also provides insight into mechanisms that are misdirected in heart disease. Some regulatory elements are altered in cardiac arrhythmias at the DNA level, for example. In contrast, histones take control in chronic heart failure. In the future, the Freiburg researchers want to identify the most important switches in this atlas in order to treat heart disease.
COMPAMED-tradefair.com; Source: Albert-Ludwigs-Universität Freiburg im Breisgau